Search research articles
Contact Us
Filters
Showing results (81-90 of 123) with videos related to
Page
of 13
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 22, 2001
Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: case report
S E Berning, T A Cherry, M D Iseman
The American Review of Respiratory Disease
|
April 1, 1974
Tuberculous pleural effusions developing during chemotherapy for pulmonary tuberculosis
R A Matthay, T A Neff, M D Iseman
Antimicrobial Agents and Chemotherapy
|
December 1, 1986
Ethambutol MICs and MBCs for Mycobacterium avium complex and Mycobacterium tuberculosis
L B Heifets, M D Iseman, P J Lindholm-Levy
The American Review of Respiratory Disease
|
December 1, 1990
Community-based short-course treatment of pulmonary tuberculosis in a developing nation. Initial report of an eight-month, largely intermittent regimen in a population with a high prevalence of drug resistance
F Manalo, F Tan, J A Sbarbaro, et al.
The American Review of Respiratory Disease
|
March 1, 1988
Rifabutine: minimal inhibitory and bactericidal concentrations for Mycobacterium tuberculosis
L B Heifets, P J Lindholm-Levy, M D Iseman
Drugs Under Experimental and Clinical Research
|
January 1, 1987
Determination of MICs of conventional and experimental drugs in liquid medium by the radiometric method against Mycobacterium avium complex
L B Heifets, M D Iseman, P J Lindholm-Levy
The American Review of Respiratory Disease
|
March 1, 1988
Combinations of rifampin or rifabutine plus ethambutol against Mycobacterium avium complex. Bactericidal synergistic, and bacteriostatic additive or synergistic effects
L B Heifets, M D Iseman, P J Lindholm-Levy
American Journal of Respiratory and Critical Care Medicine
|
June 1, 1995
Long-term safety of ofloxacin and ciprofloxacin in the treatment of mycobacterial infections
S E Berning, L Madsen, M D Iseman, et al.
Chest
|
May 1, 1987
Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous estrogens
A Shen, M D Iseman, J A Waldron, et al.
The Annals of Pharmacotherapy
|
March 13, 1998
Levofloxacin for drug-resistant Mycobacterium tuberculosis
C A Peloquin, S E Berning, G A Huitt, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 123) with videos related to
Sort By:
Page
of 13
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 22, 2001
Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: case report
S E Berning, T A Cherry, M D Iseman
The American Review of Respiratory Disease
|
April 1, 1974
Tuberculous pleural effusions developing during chemotherapy for pulmonary tuberculosis
R A Matthay, T A Neff, M D Iseman
Antimicrobial Agents and Chemotherapy
|
December 1, 1986
Ethambutol MICs and MBCs for Mycobacterium avium complex and Mycobacterium tuberculosis
L B Heifets, M D Iseman, P J Lindholm-Levy
The American Review of Respiratory Disease
|
December 1, 1990
Community-based short-course treatment of pulmonary tuberculosis in a developing nation. Initial report of an eight-month, largely intermittent regimen in a population with a high prevalence of drug resistance
F Manalo, F Tan, J A Sbarbaro, et al.
The American Review of Respiratory Disease
|
March 1, 1988
Rifabutine: minimal inhibitory and bactericidal concentrations for Mycobacterium tuberculosis
L B Heifets, P J Lindholm-Levy, M D Iseman
Drugs Under Experimental and Clinical Research
|
January 1, 1987
Determination of MICs of conventional and experimental drugs in liquid medium by the radiometric method against Mycobacterium avium complex
L B Heifets, M D Iseman, P J Lindholm-Levy
The American Review of Respiratory Disease
|
March 1, 1988
Combinations of rifampin or rifabutine plus ethambutol against Mycobacterium avium complex. Bactericidal synergistic, and bacteriostatic additive or synergistic effects
L B Heifets, M D Iseman, P J Lindholm-Levy
American Journal of Respiratory and Critical Care Medicine
|
June 1, 1995
Long-term safety of ofloxacin and ciprofloxacin in the treatment of mycobacterial infections
S E Berning, L Madsen, M D Iseman, et al.
Chest
|
May 1, 1987
Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous estrogens
A Shen, M D Iseman, J A Waldron, et al.
The Annals of Pharmacotherapy
|
March 13, 1998
Levofloxacin for drug-resistant Mycobacterium tuberculosis
C A Peloquin, S E Berning, G A Huitt, et al.
Page
of 13